Company Optipharm.CO.,LTD

Company Optipharm.CO.,LTD

A153710

KR7153710009

Pharmaceuticals

Equities

A153710

KR7153710009

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Veterinary Drugs

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Veterinary Drugs

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
6,690 ^KRW	+0.15%		+0.30%	-4.84%

2023	Optipharm.CO.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2022	Optipharm.CO.,LTD(KOSDAQ:A153710) dropped from S&P Global BMI Index	CI

Optipharm.CO.,LTD is a Korea-based company mainly engaged in the production and sale of veterinary drugs. The Company operates its business through two segments. The Sale Business segment is involved in the provision of livestock disease appraisal services, animal drug distribution, and the manufacturing and sale of feed additives. The New Business segment is engaged in research and development of heterologous organisms, virus like particle (VLP) vaccines, and human diagnostic kits. Heterogeneous organ products include heterologous skin, xenogeneic islets and xenogeneic corneal products, among others. VLP vaccines include VLP based animal combined vaccines and human papillomavirus (HPV) vaccines for the human body, among others. Human body diagnostic kits include human breast cancer and cervical cancer diagnostic reagents, among others. The Company distributes its products within the domestic market and to overseas markets.

KRW in Million	2022	Weight	2023	Weight	Delta
Animal Medicine 54.2 %	9,185	57.4 %	9,411	54.2 %	+2.47%
Animal Disease Diagnosis 25.4 %	3,753	23.4 %	4,404	25.4 %	+17.37%
Bacteriophage 10.9 %	1,735	10.8 %	1,900	10.9 %	+9.52%
Medipig 8.5 %	1,276	8.0 %	1,470	8.5 %	+15.24%
Others 1.1 %	60	0.4 %	187	1.1 %	+210.00%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 100.0 %	16,008	100.0 %	17,373	100.0 %	+8.52%

Managers	Title	Age	Since
Hyun-Il Kim CEO	Chief Executive Officer	52	-
Ki-Myung Choi CTO	Chief Tech/Sci/R&D Officer	52	-
Beom-Gu Han BRD	Director/Board Member	55	-

Members of the board	Title	Age	Since
Hyun-Il Kim CEO	Chief Executive Officer	52	-
Ki-Myung Choi CTO	Chief Tech/Sci/R&D Officer	52	-
Young-Ho Kim BRD	Director/Board Member	47	-
Jae-Wan Park BRD	Director/Board Member	44	-
Hyeon-Wuk Choi BRD	Director/Board Member	49	-
Beom-Gu Han BRD	Director/Board Member	55	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	14,669,958	8,652,777 ( 58.98 %)	0	58.98 %

Name	Equities	%	Valuation
EASY HOLDINGS CO., LTD. 34.59 %	5,074,003	34.59 %	27 M ₩
Seon-Seok Yoo 2.727 %	400,000	2.727 %	2 M ₩
Hyun-Il Kim 1.792 %	262,844	1.792 %	1 M ₩
Chang-Hyun Cho 0.3417 %	50,120	0.3417 %	262 839 ₩
Ki-Myung Choi 0.3224 %	47,290	0.3224 %	247 998 ₩
Beom-Gu Han 0.2551 %	37,430	0.2551 %	196 290 ₩
Il-hwan Hwang 0.2386 %	35,000	0.2386 %	183 547 ₩
Se-Hun Jang 0.1735 %	25,457	0.1735 %	133 502 ₩
Choong-Seok Kim 0.1302 %	19,100	0.1302 %	100 164 ₩
Deok-Yeong Kim 0.1301 %	19,090	0.1301 %	100 112 ₩

Optipharm Co., Ltd.

63 Osongsaengmyeong 6-ro Osong-eup

28158, Cheongju

http://www.optipharm.co.kr

	1st Jan change	Capi.
OPTIPHARM.CO.,LTD	-4.84%	72.44M
ELANCO ANIMAL HEALTH INCORPORATED	-9.19%	6.67B
BLUESTAR ADISSEO COMPANY	+24.75%	3.7B
VIRBAC	-1.11%	3.21B
VIMIAN GROUP AB	+6.08%	1.52B
JINYU BIO-TECHNOLOGY CO., LTD.	-15.13%	1.37B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-25.63%	1.24B
VETOQUINOL SA	-7.62%	1.21B
WUHAN KEQIAN BIOLOGY CO.,LTD	-10.84%	1.17B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	-.--%	1.05B

Veterinary Drugs

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Veterinary Drugs